Using the Surviving Sepsis Coronavirus Disease 2019 Guidelines-Anything New Yet?

• Type of Material: Article
• Authors: Ramzy Rimawi, Emory University
• Language: English
• Date: 2020-04
• Publisher: Society of Critical Care Medicine
• Publication Version: Final Published Version
• Copyright Statement: © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.
• License: Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1097/CCE.0000000000000099
• Title of Journal or Parent Work: Critical Care Explorations
• Volume: 2
• Issue: 4
• Start Page: e0099
• End Page: e0099
• Grant/Funding Information: None declared
• Keywords: Critical Care Medicine; Sepsis; Guidelines; Coronavirus Infections
• Research Categories: Health Sciences, Epidemiology; Health Sciences, Health Care Management; Health Sciences, Public Health

Abstract

The pandemic from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible for coronavirus disease 2019 (COVID-19), has lifted the importance of critical care medicine in emerging infectious diseases. The rapidly rising infection and death rates associated with COVID-19 has caused a surge capacity and forced critical care providers to manage patients with a rapidly evolving disease they are otherwise unfamiliar with. This has caused guidance and recommendations from authorities to be volatile and rapidly evolving. For example, the personal protective equipment and isolation recommendations from the World Health Organization (WHO) rapidly changed from universal N-95 respirator masks and airborne isolation to droplet isolation, contact precautions, and eye protection on patients not undergoing aerosolizing procedures.